Updated June 27, 2007
Georgia Firm Secures $7M in New Financing to Battle Cellulite
Post a comment
Print this storyE-mail story
Share
DULUTH, Ga. —
Cellutions, a startup focused on medical devices and procedures to treat cellulite, has closed on $7 million in new funding, according to VentureWire.
The company, which was formed in 2004, landed Versant Ventures as a new investor. Existing investors Carlyle Venture partners and SV Life Sciences also participated.
Cellutions raised a $5.6 million Series A round for proof of concept and feasibility studies.
According to the firm’s Web site, cellulite affects 90 percent of post-adolescent females. Its proposed technology and procedure would be performed on an outpatient basis in what the company calls a “lunchtime” treatment.
Featured
Hot Off The Wire
- Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
- Will Cisco report progress in its turnaround efforts?
- Cisco server fire threat; Lenovo Android upgrade; cloud startup vs. Cisco; Epic's Blesinski to host awards; Google 'Solve for X'
E-mail Preferences
